SelexipagPulmonary arterial hypertension (PAH)Systemic sclerosis (SSc)SSc-PAH
…arting Selexipag within 2 years from PAH diagnosis. Reasons for Selexipag discontinuation included 5 (11.4%) adverse drug reactions (ADR)…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…arting Selexipag within 2 years from PAH diagnosis. Reasons for Selexipag discontinuation included 5 (11.4%) adverse drug reactions (ADR)…
… and enrolled adult patients with PAH already on treatment with macitentan and/or selexipag as part of combination therapy. A dedicated na…